trial · primary record
Placebo
Psoriatic Arthritis
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 644 |
| Primary completion | 2030-12-30 |
| Primary endpoint | Percentage of Participants Achieving an American College of Rheumatology (ACR) 20 Response at Week 24 |
| Registry ID | NCT07871721 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:28:30.549Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07871721
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.